Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations

NCT05891873 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2023-10-23

No results posted yet for this study

Summary

Intensive and critical care in the intensive care unit (ICU) is often associated with ICU delirium and post-ICU dementia, regardless of the nature of the primary disease or insult. Optimal practical management of ICU delirium including its screening, prevention, and treatment, is an integral part of the current recommendations for optimal ICU care, but there are large gaps in the knowledge about the optimal and most effective prevention and treatment of this complication. Information on the actual implementation of these recommendations in the Czech Republic is lacking. The diagnosis of delirium is particularly challenging in neurointensive care patients (due to overlap with symptoms of primary brain lesions) and in a paediatric population. A complementary multicentre observational 4-year follow-up study, performed in an adult neurointensive/critical care stroke cohort and in a paediatric intensive/critical care cohort in centres following currently recommended preventive measures (Delusion-deep-cz) will investigate the incidence of ICU delirium and post-ICU dementia and their modifiable and non-modifiable predisposing and precipitating risk factors. Objectives are to determine the optimal methods for diagnostic screening of these complications and for the differential diagnosis of conditions mimicking delirium (non-convulsive epileptic state) or symptoms hindering its diagnosis (aphasia), and to study the association between sleep disturbances and ICU delirium to verify the role of sleep in the pathophysiology of delirium.

Conditions

  • Delirium

Interventions

DIAGNOSTIC_TEST

CAM-ICU

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

DIAGNOSTIC_TEST

ICDSC

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

DIAGNOSTIC_TEST

4AT

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

DIAGNOSTIC_TEST

p(s)CAM-ICU

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

DIAGNOSTIC_TEST

CAPD

Patients who meet the inclusion criteria will be screened daily for delirium using the screening test mentioned above.

DIAGNOSTIC_TEST

MASTcz (The Mississippi Aphasia Screening Test)

People with aphasia will be examined by a skilled speech therapist.

DIAGNOSTIC_TEST

EEG

Patients with positive delirium will undergo EEG examination. 10-min native EEG.

Sponsors & Collaborators

  • Brno University Hospital

    collaborator OTHER
  • University Hospital, Motol

    collaborator OTHER
  • Masaryk University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-07
Primary Completion
2027-05-31
Completion
2027-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05891873 on ClinicalTrials.gov